Industry Reports Services Press Release
  •   Blogs
  • Contact us About us

    North America Aquaculture Vaccines Market Forecast 2027 By Application (Bacterial Infection, Viral Infection), By Type (Inactivated Vaccines, Live Vaccines), By Route of Administration (Immersion Vaccines, Injection Vaccines, Oral Vaccines), By Species (Salmon, Trout, Tilapia), Research Report, Country Outlook (U.S., Canada), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share
    Published Date: August 2021   |   Report ID: GR1908   |   Delivery: PDF  Request Free Sample

    North America Aquaculture Vaccines Market size surpassed USD 23.3 million in 2020 and is projected to witness over 7.3% CAGR from 2021 to 2027.

    Increasing adoption of vaccines by aquaculture farmers for increasing their income is one of the important factors that will propel the market growth. Aquaculture vaccines are type of vaccines that are used to treat diseases of fishes. There are restriction and regulation on use of antibodies for aquaculture in various countries that will drive the market revenue. Also, increase in aquaculture farming in various countries in the region will fuel the market expansion. Factors such as increasing prevalence of the bacterial infection like streptococcosis, vibriosis and pseudomonas, and others are further impelling the aquaculture industry demand.

    North America Aquaculture Vaccines Market, 2021 & 2027 (USD Mn)

    North America Aquaculture Vaccines Market, 2021 & 2027 (USD Mn)

    Get more details on this report - Request Free Sample PDF

    Development of advanced and novel vaccines for treatment of various viral and bacterial infections during fish farming will boost the North America aquaculture vaccines market growth. For instance, Hipra launched Icthiovac VR/PD injectable vaccines for treatment of pasteurellosis and vibriosis in seabass. Such strategies by major market players for development and launch of innovative vaccines will drive the market demand. However, complex procedures involved in vaccine development and stringent regulatory policies for vaccine approval will restrain the market growth.

    North America Market, By Vaccines

    Inactivated aquaculture vaccines market revenue was over USD 18.9 million in 2020. This vaccine is also called as killed vaccines that uses the method of killing pathogen that are cultured ad then developed into vaccines. Inactivated vaccines are used to produce strong immune responses. Induction of strong and long-lasting response will propel the segment growth.

    North America Market, By Route of Administration

    Immersion vaccines segment will show significant growth of 7.8% during the forecast timeframe. Immersion vaccines are used for various purposes in aquaculture farming to protect fish against bacterial and infectious diseases. Growing incidence of bacterial and viral diseases along with clinical trials and R&D activities for development of advanced and novel vaccines will drive the segment growth. Ease of administration and various other advantages associated with immersion vaccines will further boost the segment demand.

    North America Market, By Species

    The salmon segment accounted for North America aquaculture vaccines market share of 64.2% in 2020. Growing demand for salmon products with increasing demand for protection against bacterial and viral infection will fuel the segment growth. Also, ban on sales of antibiotics for aquaculture will augment the growth of the market for salmons.

    North America Market, By Application 

    Viral infection segment is set to expand at a CAGR of 7.5% to reach USD 6.1 million by 2027. Viruses in aquaculture include infectious haematopoietic necrosis viruses, infectious haemorrhagic septicaemia virus, piscine orthoreovirus, Shrimp hemocyte iridescent virus, Covert mortality nodavirus and Abalone herpesvirus. These viruses are responsible for infectious pancreatic necrosis and salmon anemia. These disorders lead to heavy economic loss in the aquaculture farming. Growing demand to minimize the economic losses and to yield a healthy fish stock will significantly boost the segment growth.  

    North America Market, By Country

    Canada aquaculture vaccines market size is predicted to register growth of 7.1% to cross a valuation of USD 25.1 million by 2027. Major players are focusing on developing novel vaccines that will render strong positive effect on country’s aquaculture industry. Growing burden of diseases such as hepatopancreatic microsporidiosis, acute hepatopancreatic necrosis diseases and others will increase the demand for better management of infectious diseases in fish livestock. Growing demand for vaccination products with increasing demand for protection against bacterial and viral infections will boost the market demand in the country.

    Competitive Industry Landscape

    Major players in North America aquaculture vaccines market are Zoetis Inc., HIPRA, Merck & Co., Inc., Tecnovax, Veterquimica S.A., and Virbac among others. among others.

    Companies undertake various strategies such as mergers, collaborations, new product launch, acquisitions, geographic expansions to strengthen their market share. For instance, in 2017, PharmaQ, a vaccine manufacturing company acquired Nordland Sett Vaks. This acquisition has helped the company to expand its product portfolio.

    Frequently Asked Question(FAQ) :

    What is the estimated valuation of the North America aquaculture vaccines market through 2027?
    The market for aquaculture vaccines in North America exceeded USD 23.3 million in 2020 and will witness a CAGR of more than 7.3% through 2027.
    What are the dynamics of immersion route of administration in the North America aquaculture vaccines industry?
    The immersion aquaculture vaccines segment could expand at a strong CAGR of 7.8% through 2027 owing to rising ease of administration and cases of bacterial diseases.
    Which are the growth prospects for North America aquaculture vaccine manufacturers in the Canada market?
    The market size for aquaculture vaccines in Canada is projected to surpass USD 25.1 million by 2027 following the presence of leading companies and increasing cases of diseases and viral infection.
    How will the viral infection application fare in the North America aquaculture vaccines sector?
    The viral infection application segment is likely to be valued at USD 6.1 million by 2027, expanding at an impressive CAGR of 7.5% during the forecast period of 2021-2027.

    Get this research report on North America Aquaculture Vaccines Market customized according to your business requirements.

    report-purchase - logo Buy Now

    Why Choose us?

    • on-time delivery On-Time Delivery

      We commit to on-time delivery of reports to keep you ahead.

    • assured quality Assured Quility

      With a wide network of industry experts and trained in-house analysts, we assure best service quality.

    • Custom Research Service

      We offer research services to meet specific client requirements and provide them with actionable insights on target markets.

    • payment security Payment Security

      Our safe payment gateway gives you full control of your personal data, at all times.

    Connect with our sales team


     [email protected]